首页> 外文期刊>Journal of Medicinal Chemistry >Design, Synthesis, and Structure?Activity Relationship Studies of a Series of [4-(4-Carboxamidobutyl)]-1-arylpiperazines: Insights into Structural Features Contributing to Dopamine D_3 versus D_2 Receptor Subtype Selectivity
【24h】

Design, Synthesis, and Structure?Activity Relationship Studies of a Series of [4-(4-Carboxamidobutyl)]-1-arylpiperazines: Insights into Structural Features Contributing to Dopamine D_3 versus D_2 Receptor Subtype Selectivity

机译:一系列[4-(4-羧酰胺丁基)]-1-芳基哌嗪的设计,合成和结构与活性关系的研究:对有助于多巴胺D_3和D_2受体亚型选择性的结构特征的见解

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Antagonist and partial agonist modulators of the dopamine D3 receptor (D3R) have emerged as promising therapeutics for the treatment of substance abuse and neuropsychiatric disorders. However, development of druglike lead compounds with selectivity for the D3 receptor has been challenging because of the high sequence homology between the D3R and the dopamine D2 receptor (D2R). In this effort, we synthesized a series of acylaminobutylpiperazines incorporating aza-aromatic units and evaluated their binding and functional activities at the D3 and D2 receptors. Docking studies and results from evaluations against a set of chimeric and mutant receptors suggest that interactions at the extracellular end of TM7 contribute to the D3R versus D2R selectivity of these ligands. Molecular insights from this study could potentially enable rational design of potent and selective D3R ligands.
机译:多巴胺D3受体(D3R)的拮抗剂和部分激动剂调节剂已成为治疗药物滥用和神经精神疾病的有前途的疗法。然而,由于D3R和多巴胺D2受体(D2R)之间的高序列同源性,开发对D3受体具有选择性的药物样前导化合物具有挑战性。在这项工作中,我们合成了一系列结合有氮杂芳族单元的酰基氨基丁基哌嗪,并评估了它们在D3和D2受体上的结合和功能活性。对接研究和针对一组嵌合和突变受体的评估结果表明,TM7胞外末端的相互作用有助于这些配体的D3R与D2R选择性。这项研究的分子洞察力可能潜在地使有效和选择性D3R配体的合理设计成为可能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号